Skip to content
This GLP
By This GLP Editorial Team · Updated September 2026Four-week fill, price behind a quiz

Remedy Meds review

A four-week fill billed monthly, and no figure a reader can see before the quiz.

The verdict

Remedy Meds sells compounded semaglutide and tirzepatide, but its public pages print no price for either. Every start button leads to a quiz that asks for height and weight first.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Prescription
Required
Compounded
Yes — not FDA-approved

Remedy Meds sells both molecules by injection, plus a microdose line and a name-brand option. The homepage lists prepaid plans alongside month-to-month billing.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages describe plans and tiers. The clinician is not described anywhere a reader can reach.

    The homepage reads "Month-to-month · Cancel anytime · HSA/FSA accepted" and "No Memberships or Hidden Fees". Each fill is a four-week supply, so a year holds thirteen fills rather than twelve.

  2. What happens when the dose goes up?

    The quiz's second screen reads "Your dose depends on your body." Nothing public states what the charge does at a higher dose. The microdose line is a separate product, not a lower rung.

  3. What the price includes

    No figure appears on the homepage, even with every FAQ opened. The start buttons for semaglutide, tirzepatide, microdose and name brand all open the same quiz. A monthly charge, whenever it is shown, buys four weeks, not a calendar month.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: Month-to-month billing is stated
  • Strength: No membership fee is claimed
  • Strength: Pays from HSA or FSA funds
  • Limitation: No price before the quiz
  • Limitation: The quiz asks for body measurements first
  • Limitation: Thirteen fills a year, not twelve
  • Limitation: No state coverage list is recorded

What the evidence says about this kind of treatment

The assessment above is about Remedy Meds. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader willing to finish the quiz who will count thirteen fills a year.
Wrong for
A reader who wants a published price before giving out health details.

The evidence behind what Remedy Meds prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How Remedy Meds compares

SellerWho it suitsGo
Prime HealthReaders who count charges rather than monthsSee Prime Health →
RestorLife MedReaders who want monitoring included rather than billed separatelySee RestorLife Med →
Revive MedsReaders who want to buy one order at a time and will get the price in writingSee Revive Meds →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: FormBlendsFormidableMDFrameworkFresh Day MedsFreya MedsFridays

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

Is a price shown before the quiz?
No. The public pages print none, and any figure appears only inside the quiz.
Is a monthly charge a calendar month?
No. Each fill is a four-week supply, so a year of monthly billing is thirteen fills.
What is the microdose line?
A separate lower-dose product with its own start button, not a lower rung of the standard plan.
This GLP Editorial TeamPublisher · Updated September 2026

How this was assessed. The four questions above are answered from Remedy Meds’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.